Cepheid Predicts Q4 Sales Dip, Flat Sales in 2009 | GenomeWeb

NEW YORK (GenomeWeb News) — Molecular diagnostics developer Cepheid said today that it expects to report revenue of around $38 million for the fourth quarter of 2008, a dip of around 6 percent from the $40.4 million it posted a year ago.

Looking at the full year, Cepheid said it expects to report revenues of $170 million, an increase of 31 percent from its full-year 2007 revenues of $129.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.